Product analysis
Co-Q10 200 mg may provide limited support for heart and blood-vessel measures. Its CoQ10 form is not identified, and the serving offers relatively weak value.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality26
The CoQ10 form is not disclosed, limiting a clear judgment of its quality. Vitamin E is identified, but its quality cannot be assessed confidently from the available information.
Ingredient Transparency72
All listed amounts are disclosed. Most forms, including CoQ10, are missing, limiting comparisons between preparations.
Value For Money40
The serving cost is relatively high for its CoQ10 contribution. Value for the vitamin E contribution remains uncertain.
Customer Satisfaction78
Customer ratings are very positive. A few hundred ratings provide a useful, though not extensive, review history.
Product Focus73
Heart and blood-vessel support is the clearest purpose. Benefits for everyday energy or faster calorie burning remain uncertain.
- Format
Softgel - Container
- 30 Softgel(s)
- Per serving
- $0.77
- Also available
Co-Q10 50 mg$20.86- Customer rating
- 4.9 · 270 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 5 Calorie(s) | |
Total Fat | 0.5 Gram(s) | |
Vitamin E (D-Alpha-Tocopherol) | 0.67 mg | |
Co-Q10 | 200 mg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
- Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
- Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
- Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
- Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.